HCA Healthcare (NYSE:HCA) Rating Reiterated by Cantor Fitzgerald

Cantor Fitzgerald restated their overweight rating on shares of HCA Healthcare (NYSE:HCA) in a research note issued to investors on Tuesday morning, Benzinga reports. The firm currently has a $335.00 price objective on the stock.

A number of other equities analysts have also commented on HCA. Wells Fargo & Company increased their price target on shares of HCA Healthcare from $303.00 to $315.00 and gave the stock an equal weight rating in a report on Thursday, March 28th. TD Cowen reduced their target price on shares of HCA Healthcare from $371.00 to $360.00 and set a buy rating on the stock in a report on Tuesday, April 30th. Oppenheimer increased their target price on shares of HCA Healthcare from $330.00 to $345.00 and gave the company an outperform rating in a report on Monday, April 29th. StockNews.com raised shares of HCA Healthcare from a buy rating to a strong-buy rating in a report on Monday. Finally, Deutsche Bank Aktiengesellschaft raised their price target on shares of HCA Healthcare from $359.00 to $375.00 and gave the stock a buy rating in a report on Friday, June 28th. Four analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, HCA Healthcare presently has a consensus rating of Moderate Buy and a consensus target price of $326.53.

HCA Healthcare Stock Performance

NYSE HCA opened at $326.55 on Tuesday. HCA Healthcare has a 1 year low of $215.96 and a 1 year high of $344.20. The company has a debt-to-equity ratio of 29.26, a current ratio of 1.16 and a quick ratio of 1.02. The stock has a market capitalization of $85.53 billion, a PE ratio of 16.28, a P/E/G ratio of 1.48 and a beta of 1.68. The company’s 50 day simple moving average is $326.21 and its two-hundred day simple moving average is $318.39.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, April 26th. The company reported $5.36 EPS for the quarter, topping analysts’ consensus estimates of $5.01 by $0.35. The firm had revenue of $17.34 billion for the quarter, compared to analyst estimates of $16.81 billion. HCA Healthcare had a net margin of 8.20% and a return on equity of 674.49%. The business’s revenue for the quarter was up 11.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $4.93 EPS. Analysts predict that HCA Healthcare will post 20.92 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, June 28th. Stockholders of record on Friday, June 14th were paid a $0.66 dividend. The ex-dividend date was Friday, June 14th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.81%. HCA Healthcare’s dividend payout ratio is presently 13.16%.

Insider Transactions at HCA Healthcare

In other news, SVP Jeffrey E. Cohen sold 1,650 shares of HCA Healthcare stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $313.00, for a total value of $516,450.00. Following the completion of the sale, the senior vice president now directly owns 5,185 shares in the company, valued at $1,622,905. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, SVP Jeffrey E. Cohen sold 1,650 shares of HCA Healthcare stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $313.00, for a total value of $516,450.00. Following the completion of the sale, the senior vice president now directly owns 5,185 shares in the company, valued at $1,622,905. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Kathryn A. Torres sold 1,863 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, May 15th. The stock was sold at an average price of $326.18, for a total transaction of $607,673.34. Following the completion of the sale, the senior vice president now owns 19,612 shares of the company’s stock, valued at $6,397,042.16. The disclosure for this sale can be found here. Insiders sold 12,397 shares of company stock worth $3,921,929 over the last three months. 1.70% of the stock is currently owned by company insiders.

Institutional Trading of HCA Healthcare

Several large investors have recently added to or reduced their stakes in HCA. AQR Capital Management LLC grew its position in HCA Healthcare by 6.7% during the third quarter. AQR Capital Management LLC now owns 65,704 shares of the company’s stock valued at $16,162,000 after buying an additional 4,109 shares during the period. Glenmede Trust Co. NA lifted its holdings in HCA Healthcare by 8.1% during the third quarter. Glenmede Trust Co. NA now owns 2,546 shares of the company’s stock valued at $626,000 after purchasing an additional 191 shares in the last quarter. Alps Advisors Inc. lifted its holdings in HCA Healthcare by 3.0% during the third quarter. Alps Advisors Inc. now owns 1,940 shares of the company’s stock valued at $477,000 after purchasing an additional 57 shares in the last quarter. Adage Capital Partners GP L.L.C. lifted its holdings in HCA Healthcare by 6.2% during the third quarter. Adage Capital Partners GP L.L.C. now owns 200,100 shares of the company’s stock valued at $49,221,000 after purchasing an additional 11,648 shares in the last quarter. Finally, EHP Funds Inc. purchased a new position in HCA Healthcare during the third quarter valued at approximately $295,000. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.